Status:
UNKNOWN
Efficacy of Iodine Complex Against COVID-19 Patients
Lead Sponsor:
Sohaib Ashraf
Conditions:
Covid19
SARS-CoV-2
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The objective of this study is to measure the effect of Iodine complex in treating the COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of symptoms and length of ho...
Detailed Description
The proposed study is a placebo-controlled, add-on, randomized trial using parallel group designs. This is a close-label and adaptive, multi-centered design with 1:1:1:1 allocation ratio and superiori...
Eligibility Criteria
Inclusion
- Positive PCR with mild to moderate disease
Exclusion
- Allergic to iodine
- Any co-morbidity other than hypertension and dietetics
Key Trial Info
Start Date :
July 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 15 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04473261
Start Date
July 14 2020
End Date
October 15 2021
Last Update
July 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaikh Zayed Hospital
Lahore, Pakistan, 54600